Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2019

Feb 14, 2020

BUY
$13.94 - $24.12 $401,472 - $694,656
28,800 New
28,800 $617,000
Q1 2019

May 15, 2019

SELL
$12.61 - $22.33 $252,200 - $446,599
-20,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.99 - $4.44 $29,900 - $44,400
10,000 Added 100.0%
20,000 $60,000
Q4 2017

Feb 14, 2018

SELL
$3.06 - $4.09 $108,630 - $145,195
-35,500 Reduced 78.02%
10,000 $40,000
Q3 2017

Nov 14, 2017

BUY
$3.03 - $3.72 $137,865 - $169,260
45,500
45,500 $159,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $246M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.